Loading…
BiomX Inc. is projected to rise to $0.2701 by 2027, a +14% move from its current price of $0.238. PHGE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.2188 | $0.238 | $0.2589 | +0.01% |
| Jul 14 | $0.2113 | $0.238 | $0.2682 | +0.02% |
| Jul 15 | $0.2057 | $0.2381 | $0.2755 | +0.03% |
| Jul 16 | $0.2012 | $0.2381 | $0.2818 | +0.03% |
| Jul 17 | $0.1972 | $0.2381 | $0.2874 | +0.04% |
| Jul 18 | $0.1937 | $0.2381 | $0.2927 | +0.05% |
| Jul 19 | $0.1906 | $0.2381 | $0.2976 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1906 | $0.2381 | $0.2976 | +0.06% |
| Week 2 | $0.1739 | $0.2383 | $0.3266 | +0.12% |
| Week 3 | $0.1621 | $0.2384 | $0.3507 | +0.18% |
| Week 4 | $0.1528 | $0.2386 | $0.3725 | +0.23% |
| Week 5 | $0.145 | $0.2387 | $0.3929 | +0.29% |
| Week 6 | $0.1384 | $0.2388 | $0.4123 | +0.35% |
| Week 7 | $0.1325 | $0.239 | $0.4309 | +0.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BiomX Inc. is a holding company in the Industrials sector. Its focus is on defense, security, and critical infrastructure technologies. The description highlights a portfolio in niches such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting.
BiomX Inc. was founded in 2015 and is based in Dover, Delaware.
The company serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers, reflecting a diversified customer base within its industrial niche. These characteristics position BiomX as a small-cap industrial player with a defense/security tech emphasis.
Overall, BiomX Inc. operates as a specialized holding company offering technologies and solutions for security and infrastructure, anchored in an industrial sector framework and a 2015 founding origin in Dover, Delaware.
BiomX Inc. (PHGE) is currently priced at $0.238 per share, reflecting a micro-cap position with a market capitalization of $2.81M and a ranking of 5380. The stock trades within a small-cap space, indicative of a niche industrial issuer.
The price outlook, based on the supplied forecast, shows a near-term flat to modestly evolving path with 2026 expected average around $0.238 and 0% ROI (neutral sentiment), followed by a sequence of potential gains into the late teens and beyond in later years. The forecast projects volatility across years, with notable strength emerging in the 2032–2050 horizon, including a 2050 average near $0.814 and a 242% ROI, signaling a potential upside despite earlier softness.
In sum, BiomX presents a fragile near-term posture with slim upside and downside risk, then a longer-term trajectory that alternates between bear phases and bullish phases, culminating in a substantial long-horizon upside estimate.
A major floor 2.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.5% away) — a key level to hold.
The nearest ceiling, 555.5% above — a clean break opens room to run.
A major ceiling 3051.3% above — clearing it would confirm fresh momentum.
Key PHGE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHGE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2782 | Sell | $0.2761 | Sell |
| MA 10 | $0.3132 | Sell | $0.3211 | Sell |
| MA 20 | $0.4138 | Sell | $0.4288 | Sell |
| MA 50 | $0.6465 | Sell | $0.9352 | Sell |
| MA 100 | $2.37 | Sell | $2.00 | Sell |
| MA 200 | $4.26 | Sell | $4.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 26.99 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -118.30 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -49.78 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -3.26 | Sell |
| Awesome (5,34) | -0.38 | Sell |
| Ultimate (7,14,28) | 4.89 | Buy |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 0.25 | Sell |
| ADX (14) | 35.11 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture shows NEUTRAL sentiment, with RSI14 at 30. The 50-day moving average sits at $0.6465, while the 200-day moving average is at $4.26.
Key near-term levels include support at $0.232 and resistance at $1.56. The 30-day price range spans from a low of $0.1366 to a high of $0.4147, and the stock exhibits very high volatility at 200% annualized. These factors suggest a cautious near-term stance with limited upside pressure from current levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.232 | $0.238 | $0.3688 | 0% | Neutral | |
| $0.196 | $0.2701 | $0.4026 | +14% | Neutral | |
| $0.1903 | $0.2788 | $0.4428 | +17% | Neutral | |
| $0.1418 | $0.2187 | $0.3647 | -8% | Neutral | |
| $0.1198 | $0.1939 | $0.3365 | -19% | Bearish | |
| $0.1677 | $0.2835 | $0.5093 | +19% | Neutral | |
| $0.1768 | $0.3118 | $0.5776 | +31% | Bullish | |
| $0.1739 | $0.3193 | $0.6079 | +34% | Bullish | |
| $0.1772 | $0.3385 | $0.6607 | +42% | Bullish | |
| $0.1373 | $0.2726 | $0.5446 | +15% | Neutral | |
| $0.1879 | $0.4175 | $0.9164 | +75% | Bullish | |
| $0.3663 | $0.814 | $1.87 | +242% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.232 | $0.238 | $0.3062 | +0.00% |
| August 2026 | $0.204 | $0.2472 | $0.3121 | +3.88% |
| September 2026 | $0.1951 | $0.2398 | $0.3091 | -2.99% |
| October 2026 | $0.2072 | $0.2578 | $0.3379 | +7.47% |
| November 2026 | $0.2193 | $0.2757 | $0.3667 | +6.95% |
| December 2026 | $0.2156 | $0.2737 | $0.3688 | -0.72% |
Click any year to see its month-by-month PHGE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PHGE is projected to trade between $0.232 and $0.3688, averaging $0.238 — a potential gain of 0% from today's $0.238. A consolidation phase looks the most probable path here.
BiomX Inc.'s 2027 outlook centres on $0.2701, within a $0.196 to $0.4026 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2028, PHGE could reach as high as $0.4428, with a base case around $0.2788 and support toward $0.1903 — roughly +17% from $0.238. A consolidation phase looks the most probable path here.
Expect PHGE to range from $0.1418 to $0.3647 through 2029. The $0.2187 average target implies a -8% move from current prices. That is -22% versus the projected 2028 average. Price action looks broadly range-bound.
The PHGE price prediction for 2030 points to an average of $0.1939 (low $0.1198, high $0.3365) — a potential decline of -19% on today's $0.238. Expect choppier, lower action through this leg of the cycle.
In 2031, PHGE is projected to trade between $0.1677 and $0.5093, averaging $0.2835 — a potential gain of +19% from today's $0.238. That is up +46% on the projected 2030 average. Price action looks broadly range-bound.
BiomX Inc.'s 2032 outlook centres on $0.3118, within a $0.1768 to $0.5776 range. That is up +10% on the projected 2031 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PHGE could reach as high as $0.6079, with a base case around $0.3193 and support toward $0.1739 — roughly +34% from $0.238. Momentum favours further upside here.
Expect PHGE to range from $0.1772 to $0.6607 through 2034. The $0.3385 average target implies a +42% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PHGE price prediction for 2035 points to an average of $0.2726 (low $0.1373, high $0.5446) — a potential gain of +15% on today's $0.238. Price action looks broadly range-bound.
In 2040, PHGE is projected to trade between $0.1879 and $0.9164, averaging $0.4175 — a potential gain of +75% from today's $0.238. That is up +53% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BiomX Inc.'s 2050 outlook centres on $0.814, within a $0.3663 to $1.87 range. That is up +95% on the projected 2040 average. That marks a +242% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PHGE today (≈ 4,201.680672 PHGE) could be worth
$3,420.2
+$2,420.2 (+242%) by 2050 · US Dollar
Based on the average projected PHGE price of $0.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHGEwould be worth at today's price.
$1,000 invested in PHGE on Jul 10, 2025 (≈ 128.369705 PHGE) would be worth
$30.55
-$969.45 (-96.9%) today · 0.03× · US Dollar
Based on a PHGE entry price of $7.79 vs. today's $0.238.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.319 | $746.08 | -25.4% |
| 1 month ago | $0.64 | $371.88 | -62.8% |
| 3 months ago | $2.89 | $82.35 | -91.8% |
| 6 months ago | $2.25 | $105.78 | -89.4% |
| 1 year ago | $7.79 | $30.55 | -96.9% |
| All time (5.0y) ago | $1,088.7 | $0.22 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHGE forecast.
Our base-case forecast reaches $0.48 around 2050.
Implied market cap at $0.48: $5.66M
The multi-year forecast outlines a mixed trajectory with clear inflection points. In 2030 the average price is projected at $0.1939, with a min of $0.1198 and a max of $0.3365, and a -18.5% ROI under a BEARISH sentiment.
From 2032 through 2034, the outlook turns more favorable, with average prices of $0.3118 (31% ROI), $0.3193 (34.1% ROI), and $0.3385 (42.2% ROI) respectively, supported by BULLISH momentum. The 2040 forecast points to $0.4175 average and 75.4% ROI, while 2050 shows a strong upside with an average of $0.814, a max of $1.87, and a 242% ROI under a BULLISH sentiment.
These are forecast estimates and carry uncertainty. The path indicates substantial upside potential in the long term, but also notable downside risk in the nearer horizon, reflecting a volatile return profile for BiomX Inc.
Tap a question to reveal the answer.
2030 min $0.1198, avg $0.1939, max $0.3365; ROI -18.5%; sentiment BEARISH.
Forecasts show a neutral near term (2026 avg $0.238; ROI 0%) with potential upside in later years (2032-2034 avg prices around $0.31-$0.34 and ROIs from 31% to 42.2%), culminating in a 2050 average of $0.814 and a 242% ROI; however, there is risk, including a bearish 2030 period.
Yes. The 2050 forecast includes a max price of $1.87, indicating the possibility of surpassing $1 in the long term.
Sentiment NEUTRAL; RSI14 is 30. SMA50 is $0.6465; SMA200 is $4.26. Support is $0.232 and resistance is $1.56. The thirty-day range is $0.1366 to $0.4147, with annualized volatility at 200%.
The 2050 forecast shows min $0.3663, avg $0.814, max $1.87 with ROI 242% and sentiment BULLISH.
BiomX Inc. Community Discussion
0Share your BiomX Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.